Cargando…
The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile?
| Autores principales: | , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
AME Publishing Company
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632578/ https://www.ncbi.nlm.nih.gov/pubmed/37970606 http://dx.doi.org/10.21037/atm-23-1608 |
| _version_ | 1785146142759059456 |
|---|---|
| author | Quesada, Stanislas Jacot, William |
| author_facet | Quesada, Stanislas Jacot, William |
| author_sort | Quesada, Stanislas |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10632578 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | AME Publishing Company |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106325782023-11-15 The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? Quesada, Stanislas Jacot, William Ann Transl Med Editorial Commentary | Biomarkers Sciences AME Publishing Company 2023-08-29 2023-10-25 /pmc/articles/PMC10632578/ /pubmed/37970606 http://dx.doi.org/10.21037/atm-23-1608 Text en 2023 Annals of Translational Medicine. All rights reserved. https://creativecommons.org/licenses/by-nc-nd/4.0/Open Access Statement: This is an Open Access article distributed in accordance with the Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International License (CC BY-NC-ND 4.0), which permits the non-commercial replication and distribution of the article with the strict proviso that no changes or edits are made and the original work is properly cited (including links to both the formal publication through the relevant DOI and the license). See: https://creativecommons.org/licenses/by-nc-nd/4.0 (https://creativecommons.org/licenses/by-nc-nd/4.0/) . |
| spellingShingle | Editorial Commentary | Biomarkers Sciences Quesada, Stanislas Jacot, William The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? |
| title | The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? |
| title_full | The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? |
| title_fullStr | The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? |
| title_full_unstemmed | The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? |
| title_short | The quest for the optimal biomarker: is extending the spectrum of targeted PIK3CA mutations in breast cancer carcinoma worthwhile? |
| title_sort | quest for the optimal biomarker: is extending the spectrum of targeted pik3ca mutations in breast cancer carcinoma worthwhile? |
| topic | Editorial Commentary | Biomarkers Sciences |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10632578/ https://www.ncbi.nlm.nih.gov/pubmed/37970606 http://dx.doi.org/10.21037/atm-23-1608 |
| work_keys_str_mv | AT quesadastanislas thequestfortheoptimalbiomarkerisextendingthespectrumoftargetedpik3camutationsinbreastcancercarcinomaworthwhile AT jacotwilliam thequestfortheoptimalbiomarkerisextendingthespectrumoftargetedpik3camutationsinbreastcancercarcinomaworthwhile AT quesadastanislas questfortheoptimalbiomarkerisextendingthespectrumoftargetedpik3camutationsinbreastcancercarcinomaworthwhile AT jacotwilliam questfortheoptimalbiomarkerisextendingthespectrumoftargetedpik3camutationsinbreastcancercarcinomaworthwhile |